VION Biosciences Acquires Echelon Biosciences
This acquisition serves as the second investment under VION Biosciences, Iron Path Capital’s roll-up platform in the life science sector led by life science industry veteran, Mark Thornton.
MRNA Technology | 27/08/2024 | By Aishwarya | 178
WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval
This approval marks a key moment as the world's first EB virus-related mRNA therapeutic cancer vaccine to receive regulatory clearance.
MRNA Technology | 10/05/2024 | By Abha | 164
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy